Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells
- 276 Downloads
Compromised blood-brain barrier (BBB) by dysregulation of cellular junctions is a hallmark of many cerebrovascular disorders due to the pro-inflammatory cytokines action. Interleukin 6 (IL6) is implicated in inflammatory processes and in secondary brain injury after subarachnoid hemorrhage (SAH) but its role in the maintenance of cerebral endothelium still requires a precise elucidation. Although IL6 has been shown to exert pro-inflammatory action on brain microvascular endothelial cells (ECs), the expression of one of the IL6 receptors, the IL6R is controversially discussed. In attempt to reach more clarity in this issue, we present here an evident baseline expression of the IL6R in BBB endothelium in vivo and in an in vitro model of the BBB, the cEND cell line. A significantly increased expression of IL6R and its ligand was observed in BBB capillaries 2 days after experimental SAH in mice. In vitro, we saw IL6 administration resulting in an intracellular and extracellular elevation of IL6 protein, which was accompanied by a reduced expression of tight and adherens junctions, claudin-5, occludin, and vascular-endothelial (VE-) cadherin. By functional assays, we could demonstrate IL6-incubated brain ECs to lose their endothelial integrity that can be attenuated by inhibiting the IL6R. Blockade of the IL6R by a neutralizing antibody has reconstituted the intercellular junction expression to the control level and caused a restoration of the transendothelial electrical resistance of the cEND cell monolayer. Our findings add depth to the current understanding of the involvement of the endothelial IL6R in the loss of EC integrity implicating potential therapy options.
KeywordsBlood-brain barrier Cytokine Endothelial cells Inflammation Interleukin 6 Subarachnoid hemorrhage
This study was financially supported by Deutsche Forschungsgemeinschaft (SFB TRR43) and Bundesministerium für Bildung und Forschung (Center for Stroke Research Berlin) to PV.
The authors are grateful to Irina Kremenetskaia for excellent technical assistance.
KGBL, UCS, and PV designed the experiments and supervised the project. KGBL, JW, AF, MNK, and JR collected, analyzed, and interpreted the data. KGBL and PV interpreted the data and critically drafted and/or revised the manuscript. All authors were involved in interpretation of the data and critical revision of the manuscript, have approved the final version of the manuscript, and agree to be accountable for all aspects of the work.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that no conflict of interest exists.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- 4.Walsh TG, Murphy RP, Fitzpatrick P, Rochfort KD, Guinan AF, Murphy A, et al. Stabilization of brain microvascular endothelial barrier function by shear stress involves VE-cadherin signaling leading to modulation of pTyr-occludin levels. J Cell Physiol. 2011;226(11):3053–63. https://doi.org/10.1002/jcp.22655.CrossRefPubMedGoogle Scholar
- 7.Atangana E, Schneider UC, Blecharz K, Magrini S, Wagner J, Nieminen-Kelhä M, et al. Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH). Transl Stroke Res. 2017;8(2):144–56. https://doi.org/10.1007/s12975-016-0485-3.CrossRefPubMedGoogle Scholar
- 10.Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol. 2008;586(7):1937–49. https://doi.org/10.1113/jphysiol.2007.146852.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Ghori A, Freimann FB, Nieminen-Kelhä M, Kremenetskaia I, Gertz K, Endres M, et al. EphrinB2 activation enhances vascular repair mechanisms and reduces brain swelling after mild cerebral ischemia. Arterioscler Thromb Vasc Biol. 2017;37(5):867–78. https://doi.org/10.1161/ATVBAHA.116.308620.CrossRefPubMedGoogle Scholar
- 23.Förster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol. 2005;565(2):475–86. https://doi.org/10.1113/jphysiol.2005.084038.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Rochfort KD, Collins LE, Murphy RP, Cummins PM. Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One. 2014;9(7):e101815. https://doi.org/10.1371/journal.pone.0101815.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Eskilsson A, Mirrasekhian E, Dufour S, Schwaninger M, Engblom D, Blomqvist A. Immune-induced fever is mediated by IL-6 receptors on brain endothelial cells coupled to STAT3-dependent induction of brain endothelial prostaglandin synthesis. J Neurosci. 2014;34(48):15957–61. https://doi.org/10.1523/JNEUROSCI.3520-14.2014.CrossRefPubMedGoogle Scholar
- 32.Rochfort KD, Collins LE, McLoughlin A, Cummins PM. Tumour necrosis factor-α-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6. J Neurochem. 2016;136(3):564–72. https://doi.org/10.1111/jnc.13408.CrossRefPubMedGoogle Scholar